Pergamum AB
Records under this name other than the patents Pergamum AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,846,608 | Human Lactoferrin Derived Peptides and Their Use Lapsed on the fee record Ended Sep 30, 2026 · High confidence | Lapsed on the fee record | Ended Sep 30, 2026 | High confidence |
| US 8,815,812 | Synthetic Arginine Substituted Peptides and Their Use Formerly held Lapsed on the fee record Ended Aug 26, 2026 · High confidence | Lapsed on the fee record | Ended Aug 26, 2026 | High confidence |
| US 9,878,019 | Hyaluronic acid containing compositions for prevention of the formation of post-surgical scars and post-surgical adhesions Lapsed on the fee record Ended Jan 30, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 30, 2026 | From the USPTO record |
| US 11,000,574 | Hyaluronic acid containing compositions for prevention of the formation of post-surgical scars and post-surgical adhesions Lapsed on the fee record Ended May 11, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 11, 2025 | From the USPTO record |
| US 8,227,406 | Antimicrobial peptides Lapsed on the fee record Ended Jul 24, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jul 24, 2024 | From the USPTO record |
| US 9,132,165 | Synthetic peptides and their use Lapsed on the fee record Ended Sep 15, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 15, 2023 | From the USPTO record |
| US 7,928,185 | Synthetic Arginine Substituted Peptides and Their Use Formerly held Lapsed on the fee record Ended Apr 19, 2023 · High confidence | Lapsed on the fee record | Ended Apr 19, 2023 | High confidence |
| US 7,427,589 | Use of cytokine inhibitors Term ended Term ended Jun 3, 2022 · From the USPTO record | Term ended | Term ended Jun 3, 2022 | From the USPTO record |
| US 7,994,116 | Methods for reduction of adhesion formation using cytokine inhibitors Term ended Term ended Apr 20, 2022 · From the USPTO record | Term ended | Term ended Apr 20, 2022 | From the USPTO record |
| US 7,253,143 | Peptides based on the sequence of human lactoferrin and their use Term ended Term ended Jul 6, 2019 · From the USPTO record | Term ended | Term ended Jul 6, 2019 | From the USPTO record |